Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP

Journal of Neurogenetics

Volumn 29, Issue 2-3, 2015, Pages 59-68

  Cheng, Ching Wei ^a,b   Lin, Meng Jau ^b   Shen, Che Kun James ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

Author keywords

Amyotrophic lateral sclerosis; D42ts GAL4; Drosophila; lifespan; locomotor activity; TDP 43

Indexed keywords

RAPAMYCIN; TAR DNA BINDING PROTEIN; THYMIDINE DIPHOSPHATE; DNA BINDING PROTEIN; PROTEIN TDP-43;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DROSOPHILA; FEMALE; LOCOMOTION; MALE; MOTONEURON; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; THERAPY EFFECT; THORACIC GANGLION; ANIMAL; DISEASE MODEL; DROSOPHILA MELANOGASTER; DRUG EFFECTS; GENETICS; METABOLISM; MOTOR ACTIVITY; MUTATION; NERVE CELL; TRANSGENIC ANIMAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DROSOPHILA MELANOGASTER; MOTOR ACTIVITY; MUTATION; NEURONS; SIROLIMUS;

EID: 84947026284     PISSN: 01677063     EISSN: 15635260     Source Type: Journal    
DOI: 10.3109/01677063.2015.1077832     Document Type: Article

References (84)

1. Aoki, N., Murray, M.E., Ogaki, K., Fujioka, S., Rutherford, N.J., Rademakers, R., et al. (2015). Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta Neuropathol, 129, 53-64
2. Ayala, Y.M., Misteli, T., &, Baralle, F.E. (2008). TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proc Natl Acad Sci U S A, 105, 3785-3789
3. Barmada, S.J., Serio, A., Arjun, A., Bilican, B., Daub, A., Ando, D.M., et al. (2014). Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol, 10, 677-685
4. Benzer, S. (1967). Behavioral mutants of Drosophila isolated by countercurrent distribution. Proc Natl Acad Sci U S A, 58, 1112-1119
5. Bose, J.K., Huang, C.C., &, Shen, C.K. (2011). Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem, 286, 44441-44448
6. Bose, J.K., Wang, I.F., Hung, L., Tarn, W.Y., &, Shen, C.K. (2008). TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem, 283, 28852-28859
7. Brady, O.A., Meng, P., Zheng, Y., Mao, Y., &, Hu, F. (2011). Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1. J Neurochem, 116, 248-259
8. Buratti, E., &, Baralle, F.E. (2001). Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem, 276, 36337-36343
9. Buratti, E., &, Baralle, F.E. (2009). The molecular links between TDP-43 dysfunction and neurodegeneration. Adv Genet, 66, 1-34
10. Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S., Ayala, Y.M., &, Baralle, F.E. (2005). TDP-43 binds heterogeneous nuclear ribo nucleoprotein A/B through its C-Terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem, 280, 37572-37584
11. Buratti, E., De Conti, L., Stuani, C., Romano, M., Baralle, M., &, Baralle, F. (2010). Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J, 277, 2268-2281
12. Buratti, E., Dork, T., Zuccato, E., Pagani, F., Romano, M., &, Baralle, F.E. (2001). Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J, 20, 1774-1784
13. Caccamo, A., Majumder, S., Deng, J.J., Bai, Y., Thornton, F.B., &, Oddo, S. (2009). Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J Biol Chem, 284, 27416-27424
14. Caccamo, A., Majumder, S., Richardson, A., Strong, R., &, Oddo, S. (2010). Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem, 285, 13107-13120
15. Chen-Plotkin, A.S., Lee, V.M., &, Trojanowski, J.Q. (2010). TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol, 6, 211-220
16. Chiang, P.M., Ling, J., Jeong, Y.H., Price, D.L., Aja, S.M., &, Wong, P.C. (2010). Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci U S A, 107, 16320-16324
17. Crews, L., Spencer, B., Desplats, P., Patrick, C., Paulino, A., Rockenstein, E., et al. (2010). Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PloS One, 5, e9313
18. Diaper, D.C., Adachi, Y., Sutcliffe, B., Humphrey, D.M., Elliott, C.J., Stepto, A., et al. (2013). Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes. Hum Mol Genet, 22, 1539-1557
19. Estes, P.S., Boehringer, A., Zwick, R., Tang, J.E., Grigsby, B., &, Zarnescu, D.C. (2011). Wild-Type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet, 20, 2308-2321
20. Feiguin, F., Godena, V.K., Romano, G., D'Ambrogio, A., Klima, R., &, Baralle, F.E. (2009). Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett, 583, 1586-1592
21. Fiesel, F.C., Voigt, A., Weber, S.S., Van den Haute, C., Waldenmaier, A., Gorner, K., et al. (2010). Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J, 29, 209-221
22. Fuentealba, R.A., Udan, M., Bell, S., Wegorzewska, I., Shao, J., Diamond, M.I., et al. (2010). Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J Biol Chem, 285, 26304-26314
23. Gendron, T.F., Josephs, K.A., &, Petrucelli, L. (2010). Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration. Neuropathol Appl Neurobiol, 36, 97-112
24. Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S.R., Jangamreddy, J.R., Mehrpour, M., et al. (2014). Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol, 112, 24-49
25. Gijselinck, I., Sleegers, K., Engelborghs, S., Robberecht, W., Martin, J.J., Vandenberghe, R., et al. (2009). Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol Aging, 30, 1329-1331
26. Grad, L.I., Fernando, S.M., &, Cashman, N.R. (2015). From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis. Neurobiol Dis, 77, 257-265
27. Gregory, J.M., Barros, T.P., Meehan, S., Dobson, C.M., &, Luheshi, L.M. (2012). The aggregation and neurotoxicity of TDP-43 and its ALS-Associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila. PloS One, 7, e31899
28. Guerreiro, R.J., Schymick, J.C., Crews, C., Singleton, A., Hardy, J., &, Traynor, B.J. (2008). TDP-43 is not a common cause of sporadic amyotrophic lateral sclerosis. PloS One, 3, e2450
29. Hanson, K.A., Kim, S.H., Wassarman, D.A., &, Tibbetts, R.S. (2010). Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS). J Biol Chem, 285, 11068-11072
30. Harris, H., &, Rubinsztein, D.C. (2012). Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol, 8, 108-117
31. Hazelett, D.J., Chang, J.C., Lakeland, D.L., &, Morton, D.B. (2012). Comparison of parallel high-Throughput RNA sequencing between knockout of TDP-43 and its overexpression reveals primarily nonreciprocal and nonoverlapping gene expression changes in the central nervous system of Drosophila. G3 (Bethesda), 2, 789-802
32. Huang, C., Tong, J., Bi, F., Zhou, H., &, Xia, X.G. (2012). Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats. J Clin Invest, 122, 107-118
33. Huang, C.C., Bose, J.K., Majumder, P., Lee, K.H., Huang, J.T., Huang, J.K., &, Shen, C.K. (2014). Metabolism and mis-metabolism of the neuropathological signature protein TDP-43. J Cell Sci, 127, 3024-3038
34. Igaz, L.M., Kwong, L.K., Lee, E.B., Chen-Plotkin, A., Swanson, E., Unger, T., et al. (2011). Dysregulation of the ALS-Associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest, 121, 726-738
35. Iguchi, Y., Katsuno, M., Niwa, J., Takagi, S., Ishigaki, S., Ikenaka, K., et al. (2013). Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain, 136, 1371-1382
36. Janssens, J., Wils, H., Kleinberger, G., Joris, G., Cuijt, I., Ceuterick-de Groote, C., et al. (2013). Overexpression of ALS-Associated p.M337V human TDP-43 in mice worsens disease features compared to wild-Type human TDP-43 mice. Mol Neurobiol, 48, 22-35.
37. Joardar, A., Menzl, J., Podolsky, T.C., Manzo, E., Estes, P.S., Ashford, S., &, Zarnescu, D.C. (2015). PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43. Hum Mol Genet, 24, 1741-1754
38. Kim, H.J., Raphael, A.R., LaDow, E.S., McGurk, L., Weber, R.A., Trojanowski, J.Q., et al. (2014). Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet, 46, 152-160
39. Kim, S.H., Shi, Y., Hanson, K.A., Williams, L.M., Sakasai, R., Bowler, M.J., &, Tibbetts, R.S. (2009). Potentiation of amyotrophic lateral sclerosis (ALS)-Associated TDP-43 aggregation by the proteasome-Targeting factor, ubiquilin 1. J Biol Chem, 284, 8083-8092
40. Kuo, P.H., Doudeva, L.G., Wang, Y.T., Shen, C.K., &, Yuan, H.S. (2009). Structural insights into TDP-43 in nucleic-Acid binding and domain interactions. Nucleic Acids Res, 37, 1799-1808
41. Lacin, H., Zhu, Y., Wilson, B.A., &, Skeath, J.B. (2014). Transcription factor expression uniquely identifies most postembryonic neuronal lineages in the Drosophila thoracic central nervous system. Development, 141, 1011-1021
42. Lattante, S., Rouleau, G.A., &, Kabashi, E. (2013). TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum Mutat, 34, 812-826
43. Li, Y., Ray, P., Rao, E.J., Shi, C., Guo, W., Chen, X., et al. (2010). A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci U S A, 107, 3169-3174
44. Liachko, N.F., Guthrie, C.R., &, Kraemer, B.C. (2010). Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci, 30, 16208-16219
45. Lin, M.J., Cheng, C.W., &, Shen, C.K. (2011). Neuronal function and dysfunction of Drosophila dTDP. PloS One, 6, e20371
46. Ling, S.C., Albuquerque, C.P., Han, J.S., Lagier-Tourenne, C., Tokunaga, S., Zhou, H., &, Cleveland, D.W. (2010). ALS-Associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A, 107, 13318-13323
47. Ling, S.C., Polymenidou, M., &, Cleveland, D.W. (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron, 79, 416-438
48. Logroscino, G., Traynor, B.J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R.J., et al. (2010). Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry, 81, 385-390
49. Lu, Y., Ferris, J., &, Gao, F.B. (2009). Frontotemporal dementia and amyotrophic lateral sclerosis-Associated disease protein TDP-43 promotes dendritic branching. Mol Brain, 2, 30
50. Mackenzie, I.R., Bigio, E.H., Ince, P.G., Geser, F., Neumann, M., Cairns, N.J., et al. (2007). Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol, 61, 427-434
51. Mackenzie, I.R., Rademakers, R., &, Neumann, M. (2010). TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol, 9, 995-1007
52. Mizushima, N. (2007). Autophagy: process and function. Genes Dev, 21, 2861-2873
53. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130-133
54. Odden, J.P., Holbrook, S., &, Doe, C.Q. (2002). Drosophila HB9 is expressed in a subset of motoneurons and interneurons, where it regulates gene expression and axon pathfinding. J Neurosci, 22, 9143-9149
55. Ou, S.H., Wu, F., Harrich, D., Garcia-Martinez, L.F., &, Gaynor, R.B. (1995). Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol, 69, 3584-3596
56. Pircs, K., Nagy, P., Varga, A., Venkei, Z., Erdi, B., Hegedus, K., &, Juhasz, G. (2012). Advantages and limitations of different p62-based assays for estimating autophagic activity in Drosophila. PloS One, 7, e44214
57. Polymenidou, M., Lagier-Tourenne, C., Hutt, K.R., Huelga, S.C., Moran, J., Liang, T.Y., et al. (2011). Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci, 14, 459-468
58. Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., et al. (2004). Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet, 36, 585-595
59. Renton, A.E., Chio, A., &, Traynor, B.J. (2014). State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci, 17, 17-23
60. Rowland, L.P., &, Shneider, N.A. (2001). Amyotrophic lateral sclerosis. N Engl J Med, 344, 1688-1700
61. Salado, I.G., Redondo, M., Bello, M.L., Perez, C., Liachko, N.F., Kraemer, B.C., et al. (2014). Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. J Med Chem, 57, 2755-2772
62. Sarkar, S., Perlstein, E.O., Imarisio, S., Pineau, S., Cordenier, A., Maglathlin, R.L., et al. (2007). Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol, 3, 331-338
63. Spilman, P., Podlutskaya, N., Hart, M.J., Debnath, J., Gorostiza, O., Bredesen, D., et al. (2010). Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PloS One, 5, e9979
64. Strong, M.J., Volkening, K., Hammond, R., Yang, W., Strong, W., Leystra-Lantz, C., &, Shoesmith, C. (2007). TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci, 35, 320-327
65. Tatom, J.B., Wang, D.B., Dayton, R.D., Skalli, O., Hutton, M.L., Dickson, D.W., &, Klein, R.L. (2009). Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression. Mol Ther, 17, 607-613
66. Tollervey, J.R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., et al. (2011). Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci, 14, 452-458
67. Tooze, S.A., &, Schiavo, G. (2008). Liaisons dangereuses: autophagy, neuronal survival and neurodegeneration. Curr Opin Neurobiol, 18, 504-515
68. Tsai, K.J., Yang, C.H., Fang, Y.H., Cho, K.H., Chien, W.L., Wang, W.T., et al. (2010). Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J Exp Med, 207, 1661-1673
69. Uchida, A., Sasaguri, H., Kimura, N., Tajiri, M., Ohkubo, T., Ono, F., et al. (2012). Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain, 135, 833-846
70. Vaccaro, A., Tauffenberger, A., Aggad, D., Rouleau, G., Drapeau, P., &, Parker, J.A. (2012). Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans. PloS One, 7, e31321
71. Van Langenhove, T., van der Zee, J., &, Van Broeckhoven, C. (2012). The molecular basis of the frontotemporal lobar degeneration-Amyotrophic lateral sclerosis spectrum. Ann Med, 44, 817-828
72. Voigt, A., Herholz, D., Fiesel, F.C., Kaur, K., Muller, D., Karsten, P., et al. (2010). TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PloS one, 5, e12247
73. Wang, H.Y., Wang, I.F., Bose, J., &, Shen, C.K. (2004). Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics, 83, 130-139
74. Wang, I.F., Guo, B.S., Liu, Y.C., Wu, C.C., Yang, C.H., Tsai, K.J., &, Shen, C.K. (2012). Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci U S A, 109, 15024-15029
75. Wang, I.F., Tsai, K.J., &, Shen, C.K. (2013). Autophagy activation ameliorates neuronal pathogenesis of FTLD-U mice: a new light for treatment of TARDBP/TDP-43 proteinopathies. Autophagy, 9, 239-240
76. Wang, I.F., Wu, L.S., Chang, H.Y., &, Shen, C.K. (2008a). TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem, 105, 797-806
77. Wang, I.F., Wu, L.S., &, Shen, C.K. (2008b). TDP-43: an emerging new player in neurodegenerative diseases. Trends Mol Med, 14, 479-485
78. Watson, M.R., Lagow, R.D., Xu, K., Zhang, B., &, Bonini, N.M. (2008). A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem, 283, 24972-24981
79. Wegorzewska, I., Bell, S., Cairns, N.J., Miller, T.M., &, Baloh, R.H. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A, 106, 18809-18814
80. Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., et al. (2010). TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A, 107, 3858-3863
81. Wu, L.S., Cheng, W.C., Hou, S.C., Yan, Y.T., Jiang, S.T., &, Shen, C.K. (2010). TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis, 48, 56-62
82. Wu, L.S., Cheng, W.C., &, Shen, C.K. (2012). Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J Biol Chem, 287, 27335-27344
83. Xu, Y.F., Gendron, T.F., Zhang, Y.J., Lin, W.L., D'Alton, S., Sheng, H., et al. (2010). Wild-Type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci, 30, 10851-10859
84. Zhang, X., Li, L., Chen, S., Yang, D., Wang, Y., Wang, Z., &, Le, W. (2011). Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy, 7, 412-425